These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 35638848)
1. Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies. Price GE; Lo CY; Misplon JA; Epstein SL J Virol; 2022 Jun; 96(12):e0032022. PubMed ID: 35638848 [TBL] [Abstract][Full Text] [Related]
2. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model. Dhakal S; Loube J; Misplon JA; Lo CY; Creisher PS; Mulka KR; Deshpande S; Mitzner W; Klein SL; Epstein SL J Virol; 2021 Apr; 95(9):. PubMed ID: 33627390 [TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model. Price GE; Lo CY; Misplon JA; Epstein SL J Virol; 2014 Jun; 88(11):6019-30. PubMed ID: 24623430 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice. Asthagiri Arunkumar G; McMahon M; Pavot V; Aramouni M; Ioannou A; Lambe T; Gilbert S; Krammer F Vaccine; 2019 Sep; 37(37):5567-5577. PubMed ID: 31399277 [TBL] [Abstract][Full Text] [Related]
5. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793 [TBL] [Abstract][Full Text] [Related]
6. Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen. Price GE; Lo CY; Misplon JA; Epstein SL Vaccine; 2018 Aug; 36(32 Pt B):4910-4918. PubMed ID: 30037481 [TBL] [Abstract][Full Text] [Related]
7. Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice. Lo CY; Misplon JA; Li X; Price GE; Ye Z; Epstein SL Vaccine; 2021 Jul; 39(33):4628-4640. PubMed ID: 34226103 [TBL] [Abstract][Full Text] [Related]
8. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge. McMahon M; Asthagiri Arunkumar G; Liu WC; Stadlbauer D; Albrecht RA; Pavot V; Aramouni M; Lambe T; Gilbert SC; Krammer F Front Immunol; 2019; 10():2005. PubMed ID: 31497029 [TBL] [Abstract][Full Text] [Related]
9. Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice. Rowell J; Lo CY; Price GE; Misplon JA; Epstein SL; Garcia M Vaccine; 2018 Feb; 36(7):1008-1015. PubMed ID: 29249542 [TBL] [Abstract][Full Text] [Related]
10. Broadly Protective CD8 Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S J Virol; 2021 May; 95(12):. PubMed ID: 33827939 [TBL] [Abstract][Full Text] [Related]
11. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity. Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227 [TBL] [Abstract][Full Text] [Related]
12. Progress on adenovirus-vectored universal influenza vaccines. Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176 [TBL] [Abstract][Full Text] [Related]
13. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination. Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650 [TBL] [Abstract][Full Text] [Related]
14. Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice. Soboleski MR; Gabbard JD; Price GE; Misplon JA; Lo CY; Perez DR; Ye J; Tompkins SM; Epstein SL PLoS One; 2011; 6(7):e21937. PubMed ID: 21789196 [TBL] [Abstract][Full Text] [Related]
15. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge. Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479 [TBL] [Abstract][Full Text] [Related]